These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 20800501)
1. Synthesis and biological activities of new di- and trimeric quinoline derivatives. Broch S; Hénon H; Debaud AL; Fogeron ML; Bonnefoy-Bérard N; Anizon F; Moreau P Bioorg Med Chem; 2010 Oct; 18(19):7132-43. PubMed ID: 20800501 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and molecular modeling study of new trimeric quinoline derivatives. Saugues E; Nauton L; Théry V; Anizon F; Moreau P Bioorg Chem; 2011 Aug; 39(4):143-50. PubMed ID: 21807395 [TBL] [Abstract][Full Text] [Related]
3. The discovery of small molecule chemical probes of Bcl-X(L) and Mcl-1. Prakesch M; Denisov AY; Naim M; Gehring K; Arya P Bioorg Med Chem; 2008 Aug; 16(15):7443-9. PubMed ID: 18603434 [TBL] [Abstract][Full Text] [Related]
4. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL. Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929 [TBL] [Abstract][Full Text] [Related]
5. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction. Yin H; Lee GI; Sedey KA; Rodriguez JM; Wang HG; Sebti SM; Hamilton AD J Am Chem Soc; 2005 Apr; 127(15):5463-8. PubMed ID: 15826183 [TBL] [Abstract][Full Text] [Related]
6. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface. Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783 [TBL] [Abstract][Full Text] [Related]
7. Design and modular parallel synthesis of a MCR derived alpha-helix mimetic protein-protein interaction inhibitor scaffold. Antuch W; Menon S; Chen QZ; Lu Y; Sakamuri S; Beck B; Schauer-Vukasinović V; Agarwal S; Hess S; Dömling A Bioorg Med Chem Lett; 2006 Mar; 16(6):1740-3. PubMed ID: 16427279 [TBL] [Abstract][Full Text] [Related]
8. Diversity-oriented synthesis of a cytisine-inspired pyridone library leading to the discovery of novel inhibitors of Bcl-2. Marcaurelle LA; Johannes C; Yohannes D; Tillotson BP; Mann D Bioorg Med Chem Lett; 2009 May; 19(9):2500-3. PubMed ID: 19329314 [TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions. Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activities of polyquinoline derivatives: new Bcl-2 family protein modulators. Saugues E; Debaud AL; Anizon F; Bonnefoy N; Moreau P Eur J Med Chem; 2012 Nov; 57():112-25. PubMed ID: 23047228 [TBL] [Abstract][Full Text] [Related]
11. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer. Doshi JM; Tian D; Xing C J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155 [TBL] [Abstract][Full Text] [Related]
13. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein. Yin H; Hamilton AD Bioorg Med Chem Lett; 2004 Mar; 14(6):1375-9. PubMed ID: 15006365 [TBL] [Abstract][Full Text] [Related]